TheChineTime

AstraZeneca commits $15B to China to boost cell therapy, radioconjugates capabilities - FirstWord Pharma

2026-01-29 - 16:41

AstraZeneca commits $15B to China to boost cell therapy, radioconjugates capabilities FirstWord Pharma

Share this post: